Inside Innovation

Just over a year after going public, Absci stocks are continuing to grow. The Vancouver, Washington based company now is valued at almost $2 billion.

Eliem Therapeutics, a Redmond, Washington based biotech company has filed for IPO. The filing follows two rounds of funding which took place earlier in 2021,

Lumen Bioscience, a Seattle-based biotech company announced it will be expanding its operations and moving to Seattle’s Wallingford neighborhood to continue manufacturing proteins found in

In a growing IPO market, AbSci, Vancouver, A Washington-based biotech company prepares for a public offering, joining additional Washington state biotech startups in the public

Funding from VCs for Seattle’s life science industry grew 266% during Q1 2021 in comparison with Q1 last year. This makes Seattle the fastest-growing life

Earlier this month, Icosavax, a Seattle-based biotech company that originally launched from the University of Washington, filed for IPO. Founded in 2017, Icosavax develops vaccines

Seattle continues to be an integral player in the fight against COVID-19, with local company HDT Bio announcing it will enter early-stage clinical trials in

Absci, a Vancouver-based startup, is the latest Washington biotech company to announce its intent to go public. The company has had a robust 2021 so

Seattle was recently named the top U.S. city for LGBTQ+ employees, beating out Chicago, Washington D.C., San Francisco and New York to take the number

Congratulations are in order for sponsor company Adaptive Biotechnologies, which made Puget Sound Business Journal’s list of 2021 Best Workplaces in Washington. The annual award

Nautilus Biotechnology recently raised $345 million via SPAC to fuel a new approach that could accelerate biomedical research and transform drug development. Propelled by this

Seattle-based law firm Perkins Coie is launching The Black Boardroom Initiative, which aims to grow the diversity of S&P 500 corporate boards by increasing the